Table 1. Descriptive characteristics of EAGLE patients whose samples were used in miRNA microarray chip analysisa.
Characteristic | Adenocarcinoma (n=165) | Squamous cell carcinoma (n=125) |
---|---|---|
Median age (range) | 65 (39–79) | 70 (42–80) |
Gender | ||
Male | 89 (54%) | 122 (98%) |
Female | 76 (46%) | 3 (2%) |
Smoking, n (%) | ||
Current | 70 (42%) | 64 (51%) |
Formerb | 61 (37%) | 60 (48%) |
Never | 34 (21%) | 1 (1%) |
Average packs per day, median (25th–75th percentile)c | 1.0 (0.75–1.0) | 1.0 (1.0–1.5) |
Stage, n (%) | ||
IA | 32 (19%) | 25 (20%) |
IB | 33 (20%) | 27 (22%) |
IIA | 10 (6%) | 4 (3%) |
IIB | 33 (20%) | 38 (30%) |
IIIA | 32 (19%) | 17 (14%) |
IIIB | 14 (8%) | 13 (10%) |
IV | 11 (7%) | 1 (1%) |
Abbreviations: EAGLE=Environment And Genetics in Lung cancer Etiology; miRNA=microRNA.
Adapted from Landi et al (2010).
Former smokers were subjects who quit smoking ⩾6 months before the study.
Data available for current and former smokers only.